41 – 50 of 533
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
(
- Contribution to journal › Article
-
Mark
Desloratadine and loratadine stand out among common H1-antihistamines for association with improved breast cancer survival
(
- Contribution to journal › Article
-
Mark
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
(
- Contribution to journal › Letter
-
Mark
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk
(
- Contribution to journal › Article
-
Mark
Protein Expression in Metastatic Melanoma and the Link to Disease Presentation in a Range of Tumor Phenotypes
(
- Contribution to journal › Scientific review
-
Mark
Increased cancer risk in families with pediatric cancer is associated with gender, age, diagnosis, and degree of relation to the child
2020) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 29(11). p.2171-2179(
- Contribution to journal › Article
-
Mark
Alcohol consumption, cigarette smoking, and risk of breast cancer for BRCA1 and BRCA2 mutation carriers : Results from the BRCA1 and BRCA2 cohort consortium
(
- Contribution to journal › Article
-
Mark
Desloratadine and loratadine use associated with improved melanoma survival
(
- Contribution to journal › Letter
-
Mark
The Role of PTEN Loss in Immune Escape, Melanoma Prognosis and Therapy Response
(
- Contribution to journal › Article
-
Mark
Analysis of DNA methylation patterns in the tumor immune microenvironment of metastatic melanoma
(
- Contribution to journal › Article